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Piezo1 is a mechanosensitive cation channel with widespread
physiological importance; however, its role in the heart is poorly
understood. Cardiac fibroblasts help preservemyocardial integ-
rity and play a key role in regulating its repair and remodeling
following stress or injury. Here we investigated Piezo1 expres-
sion and function in cultured human and mouse cardiac fibro-
blasts. RT-PCR experiments confirmed that Piezo1 mRNA in
cardiac fibroblasts is expressed at levels similar to those in endo-
thelial cells. The results of a Fura-2 intracellular Ca2 assay val-
idated Piezo1 as a functional ion channel that is activated by
its agonist, Yoda1. Yoda1-induced Ca2 entry was inhibited by
Piezo1 blockers (gadolinium and ruthenium red) and was
reduced proportionally by siRNA-mediated Piezo1 knockdown
or in murine Piezo1/ cells. Results from cell-attached patch
clamp recordings on human cardiac fibroblasts established that
they contain mechanically activated ion channels and that their
pressure responses are reduced by Piezo1 knockdown. Investi-
gation of Yoda1 effects on selected remodeling genes indicated
that Piezo1 activation increases both mRNA levels and protein
secretion of IL-6, a pro-hypertrophic and profibrotic cytokine,
in a Piezo1-dependent manner. Moreover, Piezo1 knockdown
reduced basal IL-6 expression from cells cultured on softer col-
lagen-coated substrates. Multiplex kinase activity profiling
combined with kinase inhibitor experiments and phosphospe-
cific immunoblotting established that Piezo1 activation stimu-
lates IL-6 secretion via the p38mitogen-activatedprotein kinase
downstream of Ca2 entry. In summary, cardiac fibroblasts
express mechanically activated Piezo1 channels coupled to
secretion of the paracrine signaling molecule IL-6. Piezo1 may
therefore be important in regulating cardiac remodeling.
Cardiac fibroblasts play important roles in the normal phys-
iology of the heart and in its response to damage or stress.
Altered environmental stiffness and mechanical stretching of
cardiac fibroblasts, which occur secondary to fibrosis, cardiac
dilatation, or changes in the hemodynamic burden in the heart,
induce differentiation of fibroblasts into myofibroblasts with
increased expression of pro-fibrotic cytokines, extracellular
matrix (ECM)5 proteins, and ECM receptors (1–3). This pre-
serves cardiac integrity and performance, but the response can
becomemaladaptive; surplus deposition of cardiac ECMresults
in fibrosis, which increases the stiffness of themyocardium and
reduces pumping capacity (4).
Much remains unknown regarding how mechanical forces
are translated into transcriptional responses important for
determination of the fibroblast phenotype and how this can
lead to cardiac remodeling (3, 5). Stretch-activated ion channels
have been identified as candidates for cardiac mechanotrans-
ducers (6). Intracellular Ca2 controls many functions in car-
diac fibroblasts, including ECM synthesis and cell proliferation
(7, 8), and it is known that Ca2 entry through ion channels is
important for cardiac fibroblast responsiveness. For example,
TRPV4 channel–mediated Ca2 signaling has been shown to
Thisworkwas supportedbyBritishHeart FoundationPhDStudentship FS/15/
48/31665 (to N. M. B. (student), N. A. T., J. L., and D. J. B.). The authors
declare that they have no conflicts of interest with the contents of this
article.
Author’s Choice—Final versionopenaccessunder the termsof theCreative
Commons CC-BY license.
This article contains Figs. S1 and S2 and Table S1.
1 Supported by a Wellcome Trust Investigator Award (to D. J. B.).
2 Supported by Nederlandse Hartstichting to undertake a placement at the
University of Leeds as part of the Masters program offered by Maastricht
University.
3 Supported by a British Heart Foundation PhD Studentship.
4 To whom correspondence should be addressed: Discovery and Transla-
tional Science Dept., Leeds Institute of Cardiovascular andMetabolicMed-
icine, LIGHT Laboratories, Clarendon Way, University of Leeds, Leeds LS2
9JT, UK. Tel.: 44-113-3434817. E-mail: n.a.turner@leeds.ac.uk.
5 The abbreviations used are: ECM, extracellular matrix; MAPK, mitogen-acti-
vatedprotein kinase; HUVEC, humanumbilical vein endothelial cell;MACS,
magnetic antibody cell separation; Het, heterozygous; ANOVA, analysis of
variance; ERK, extracellular signal-regulated kinase; CDK, cyclin-depend-
ent kinase; JNK, c-Jun N-terminal kinase; SBS, standard bath solution; STK,
serine-threonine kinase; CF, cardiac fibroblast(s).
croARTICLE
Author’s Choice
J. Biol. Chem. (2019) 294(46) 17395–17408 17395
© 2019 Blythe et al. Published by The American Society for Biochemistry and Molecular Biology, Inc.
 at U
N
IV
ERSITY
 O
F LEED
S on D
ecem
ber 9, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
play a role in mechanosensation and differentiation of fibro-
blasts into myofibroblasts (9).
In 2010, the Piezo1 and Piezo2 proteins were identified as
the long-sought molecular carriers of an excitatory mechan-
ically activated current found in many cell types (10). Piezo1,
a nonselective cation channel, can be activated by a synthetic
small molecule called Yoda1 (11). Yoda1 was discovered in a
screen of 3.25 million compounds aiming to identify acti-
vators of Piezo1 or Piezo2 using high-throughput Ca2
imaging (11). Importantly, Yoda1 activates Piezo1 but not
Piezo2 and can do so in artificial lipid bilayers without the
need for other cellular components (11). More recently,
Yoda1 has been used to explore the gating mechanism of
Piezo1 (12). Hence, Yoda1 is a useful tool for activating the
Piezo1 channel without the need for mechanical stimulation.
Piezo1 mRNA has been detected in the murine heart,
whereas Piezo2 mRNA was barely detected (10). Piezo1 has
been shown recently to be expressed in cardiomyocytes and
up-regulated in heart failure (13). However, there are cur-
rently no reports regarding the role of Piezo1 in cardiac
fibroblasts. We hypothesized that Piezo1 plays an important
role in cardiac fibroblast function by regulating Ca2 entry
and downstream signaling.
Our data provide evidence that Piezo1 acts as a functional
Ca2-permeable mechanosensitive ion channel in murine and
human cardiac fibroblasts and that its activation by Yoda1 is
coupled to secretion of IL-6, a cytokine important in the
response to cardiac injury and hypertrophic remodeling. We
further reveal that Piezo1-induced Ca2 entry is coupled to
IL-6 expression via activation of p38 MAPK.
Results
Piezo1 expression and activity in cardiac fibroblasts
mRNA encoding Piezo1 was detected in cultured cardiac
fibroblasts frombothmouse andhumanhearts (Fig. 1,A andB).
In comparison with endothelial cells, which are known to
express high levels of this channel (14), Piezo1 mRNA expres-
sion levels in murine cardiac fibroblasts were similar to those
observed in murine pulmonary endothelial cells, and those in
human cardiac fibroblasts were similar to those in human
saphenous vein endothelial cells and human umbilical vein
endothelial cells (HUVECs) (Fig. 1, A and B). Using a magnetic
antibody cell separation (MACS) technique (15), we confirmed
that Piezo1 was expressed in the fibroblast-enriched (Col1a2-
positive) fraction of freshly isolated cells frommouse heart at a
level similar to that in the endothelial cell-enriched (Pecam-1-
positive) fraction (Fig. 1,C andD). Piezo1mRNA levels were 20
times higher in isolated cardiac fibroblasts thanMyh6-positive
cardiomyocytes when normalized to the average of three sepa-
rate housekeeping genes (Fig. 1, C and D).
Having demonstrated that cardiac fibroblasts express Piezo1
mRNA, we investigated whether the Piezo1 protein was able
to form a functional ion channel. Using the Fura-2 Ca2
indicator assay, it was found that Yoda1, a Piezo1 agonist
(11), elicited an increase in intracellular Ca2 in murine and
human cardiac fibroblasts (Fig. 1, E and F). Consistent with
the Yoda1-induced increase in intracellular Ca2 being due
to influx of extracellular Ca2 through an ion channel, the
Ca2 signal was reduced by more than 90% when extracellu-
lar Ca2 was absent in human and mouse cardiac fibroblast
cultures (Fig. 1, E and F).
Concentration–response data for Yoda1 in murine cardiac
fibroblasts revealed a marked effect at 0.3 M, and the maximal
response was generated at 10 M; the EC50 of Yoda1 was esti-
mated to be 0.72 M (Fig. 1G). This was almost identical to the
EC50 observed in human cardiac fibroblasts in similar experi-
ments (Fig. 1H) and comparable with that for mouse Piezo1
heterologously expressed in HEK T-RExTM-293 cells, where
the EC50 of Yoda1 was 0.33 M (Fig. 1I).
Gadolinium (Gd3) and ruthenium red, both nonspecific
inhibitors of mechanosensitive ion channels, including
Piezo1 (10), were used to investigate the pharmacology of the
channel. Murine cardiac fibroblasts preincubated with these
inhibitors exhibited significantly reduced Yoda1-evoked
Ca2 entry (70% reduction in both cases) (Fig. 2A). Addi-
tionally, Yoda1-evoked Ca2 entry was significantly reduced
by more than 50% by Dooku1 (Fig. 2A), an analog of Yoda1
that has antagonist properties against Yoda1 in Piezo1-over-
expressing HEK293 cells and HUVECs (16). The data were
similar in human cardiac fibroblasts, where again all three
inhibitors significantly reduced Ca2 influx in response to
Yoda1 (Fig. S1). Ca2 entry elicited by Yoda1 application was
also investigated in cardiac fibroblasts isolated from a global
heterozygous (Het) Piezo1/ mouse line. RT-PCR analysis
confirmed the predicted 50% reduction in Piezo1 mRNA
expression in cardiac fibroblasts derived from Piezo1/
hearts compared with the WT (Fig. 2B). The Ca2 response
to Yoda1 was reduced by 40% (Fig. 2C), whereas the response
to ATP was similar in cells from WT and Piezo1/ mice
(Fig. 2D). Piezo1-specific siRNA, which decreased Piezo1
mRNA expression by 80% in murine cardiac fibroblasts (Fig.
2E), reduced Yoda1-evoked Ca2 entry by a similar level
(Fig. 2F), whereas control siRNA was without effect. Similar
results were obtained with human cardiac fibroblasts (Fig. 2,
G andH). Thus, the Yoda1 response depended on Piezo1 and
was proportional to its expression level. Together, these data
establish that Yoda1-induced Ca2 entry in cardiac fibro-
blasts depends on Piezo1 expression and that the channel
has the expected pharmacological properties.
Cardiac fibroblasts containmechanically activated currents
To investigate whether cardiac fibroblasts contain mechani-
cally activated ion channels, we made cell-attached patch
recordings from human cardiac fibroblasts. Mechanical force
was applied to the patches using a fast pressure clamp system
that generated calibrated suction pulses (pressure pulses) in the
patch pipette and therefore increased membrane tension (Fig.
3A). Increased pressure caused increased inward currents up to
a limit (Fig. 3, A and B). The currents were noisy macroscopic
currents, suggesting the presence of multiple individual chan-
nels that summed to generate the overall current. The ampli-
tude of the current was highly variable between patches, as seen
by the large standard error in Fig. 3B. Despite this variability, we
estimated that the pressure required for 50% activation was
61.3 mm Hg (Fig. 3B).
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Themechanically activated channel activity is
Piezo1-dependent
To test whether the currents were Piezo1-dependent, we
systematically compared two matched groups of human car-
diac fibroblasts: one transfected with control siRNA and the
other transfected with Piezo1 siRNA. Because the transfec-
tion efficiency was estimated to be 90% at best, we expected
that at least one in every 10 recordings would be from a
nontransfected cell. To compensate for this limitation, we
made a large number of individual recordings before analyz-
ing the data (45 in total). Our overall impression was that
most Piezo1 siRNA–transfected cells showed no meaningful
current in response to pressure steps (Fig. 3C). Data for all
45 recordings are shown in Fig. 3, D and E. The high varia-
bility was again observed, but it was also visually apparent
that pressure-activated currents were more common in the
control siRNA group than in the Piezo1 siRNA group (com-
pare Fig. 3,D and E). In only two patches of the Piezo1 siRNA
group were clear pressure-activated currents observed (Fig.
3E).We suspected that these latter two recordings were from
nontransfected cells (assuming 90% transfection efficiency).
Formal analysis using two-way ANOVA on all data in the
two groups for all pressure steps (no data were excluded)
indicated that currents in the Piezo1 siRNA group were
statistically significantly different (smaller) than those in
the control siRNA group. These data suggest that human
cardiac fibroblasts express mechanically activated Piezo1
channels.
Figure 1. Piezo1 is expressed by cardiac fibroblasts and forms a functional ion channel. A and B, RT-PCR analysis of Piezo1 mRNA expression in
murine cardiac fibroblasts (CF, n  3) compared with murine pulmonary endothelial cells (PEC, n  5) (A) and human CF (n  6) compared
with human saphenous vein endothelial cells (SVEC, n  3) and HUVECs (n  3) (B). Expression was measured as percent of the housekeeping control
(Gapdh/GAPDH). C, RT-PCR analysis of Piezo1 mRNA expression in fibroblast-enriched fraction 2 (CF) and endothelial cell– enriched fraction 1 (EC)
isolated from murine heart using the MACS technique (n  4). Cardiomyocytes (CM) were isolated from separate hearts (n  2). Expression was
measured relative to three housekeeping genes (Gapdh, Actb, and Hprt) and normalized to the CF sample. D, RT-PCR analysis of cell type-specific marker
genes for CF (Col1a2), endothelial cells (Pecam1), and cardiomyocytes (Myh6) in MACS fractions as for C. E and F, representative Ca2 traces andmean
S.E. are shown. Ca2 entry was evoked by 10 M Yoda1 in murine (E) and human (F) cardiac fibroblasts in the presence or absence of extracellular Ca2.
***, p 0.001 (paired t test; n/N 3/9). G–I, Ca2 entry evoked by varying concentrations of Yoda1 application at 60 s, ranging from 0.1–10M inmurine
(G) and human (H) cardiac fibroblasts and HEK T-Rex-293 cells heterologously expressing mouse Piezo1 (I). Vehicle control is illustrated by the black
trace. Mean  S.E. are displayed as concentration–response curves, and fitted curves are plotted using a Hill equation, indicating the EC50 of Yoda1
(n/N  3/9).
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Yoda1-induced Piezo1 activation is coupled to increased Il6
gene expression
To gain insight into the functional role of Piezo1 activation in
cardiac fibroblasts, the effect of 24-h treatment with 0.5–10M
Yoda1 on the expression of selected remodeling genes in
murine fibroblasts was investigated by RT-PCR (Fig. 4, A–G).
Prolonged Yoda1 treatment did not modulate Piezo1 gene
expression (Fig. 4A), nor did it affect the expression of genes
involved in ECM turnover, including collagens I and III
(Col1a1, Col3a1) or matrix metalloproteinase 3 and 9 (Mmp3,
Mmp9) (Fig. 4, B–E). However, a concentration-dependent
increase in mRNA expression of the inflammatory/hyper-
trophic cytokine IL-6was observed, with significant 2- to 4-fold
increases observed in response to 2–10MYoda1 (Fig. 4F). This
was not a generic inflammatory response because Il1b mRNA
levels remained unaffected by Yoda1 treatment (Fig. 4G). Pro-
longed exposure to Yoda1 did not affect cell viability (Fig. 4, H
and I), although it did appear to induce amorphological change
in the cells toward a more spindle-like, less rhomboid shape
(Fig. 4I).
Piezo1 activation stimulates IL-6 expression and secretion via
p38MAP kinase
Given our recent findings regarding the potential impor-
tance of cardiac fibroblast-derived IL-6 in modulating cardiac
hypertrophy (15) and the causative link between mechanical
stimulation and cardiac hypertrophy (17), we proceeded to
interrogate themechanismbywhichPiezo1 activationwas cou-
pled to IL-6 expression. First, we explored whether mechanical
activation of cardiac fibroblasts was coupled to IL-6 expression
and whether this occurred via a Piezo1-dependent mechanism.
Cyclic stretching (1 Hz, 10% stretch) of human cardiac fibro-
blasts for 24 h had no effect on IL6mRNA levels or IL-6 protein
secretion (Fig. 5A). However, during these experiments, it
became apparent that PIEZO1 gene silencing significantly
reduced basal IL-6 expression at bothmRNA and protein levels
(independently of stretch) when cells were grown on BioFlex
plates (Fig. 5A) but not when they were maintained on regular
tissue culture plastic (Fig. 5E). The BioFlex plates have a stiff-
ness (Young’s modulus)1000 times less than standard tissue
culture plates and were coated with type I collagen. Thus, acti-
Figure 2. Yoda1-evoked Ca2 entry depends on Piezo1 expression. A, representative intracellular Ca2 traces and mean data after murine
cardiac fibroblasts were exposed to 10 M Gd3, 30 M ruthenium red (RuR), 10 M Dooku1, or vehicle (Veh) for 30 min before activation of Piezo1
by application of 2M Yoda1. Datawere normalized to vehicle-treated cells. Repeatedmeasures one-way ANOVA: p 0.0001, F 114.1 (n/N 3/9). Post
hoc test: ***, p  0.001 versus vehicle-treated cells. B, RT-PCR analysis of Piezo1 mRNA expression in cultured murine cardiac fibroblasts isolated
from WT and Piezo1/ (Het) mice. Expression is measured as percent of the housekeeping control Gapdh. ***, p  0.001 (unpaired t test, n  8). C,
representative Ca2 trace and mean data illustrating Ca2 entry elicited by 10 M Yoda in cardiac fibroblasts from WT (n/N 8/24) and Piezo1/ Het
(n/N  5/15) mice. ***, p  0.001 (unpaired t test). D, representative Ca2 trace and mean data illustrating Ca2 entry evoked by 5 M ATP in cardiac
fibroblasts from WT (n/N  4/12) and Piezo1/ (Het, n/N  3/9) mice. Unpaired t test: not significant (NS). E, RT-PCR analysis of Piezo1 mRNA ex-
pression following transfection of murine cardiac fibroblasts with Piezo1 siRNA, mock-transfected cells, and cells transfected with control siRNA.
Expression is measured as percent of the housekeeping control Gapdh. Repeated measures one-way ANOVA: p 0.0001, F 61.1 (n 3). Post hoc test:
***, p  0.001 versus mock-transfected cells. F, representative Ca2 trace and mean data showing the response to 2 M Yoda1 in murine cardiac
fibroblasts transfectedwith Piezo1-specific siRNA (P1 si.) comparedwithmock-transfected cells and cells transfectedwith control siRNA (C. si.). Repeated
measures one-way ANOVA: p 0.0001, F 72.6 (n/N 3/9). Post hoc test: ***, p 0.001 versus mock-transfected cells. G, as for E but in human cardiac
fibroblasts. Repeated measures one-way ANOVA: p 0.0002, F 50.8 (n/N 3/9). Post hoc test: ***, p 0.001 versus mock-transfected cells. H, as for
F but in human cardiac fibroblasts. Repeated measures one-way ANOVA: p  0.0108, F  10.6 (n/N  3/9). Post hoc test: *, p  0.05 versus mock-
transfected cells.
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vation of Piezo1 by chemical activation (Yoda1) or in response
to altered substrate composition/stiffness was coupled to
increased IL-6 expression in cardiac fibroblasts.
We then probed the mechanism further in murine cardiac
fibroblasts using Yoda1 as a stimulus. Il6 mRNA expression
increased in a time-dependent manner over a 2- to 24-h period
of Yoda1 treatment (Fig. 5B). This increase correlated with an
increase in IL-6 protein secretion (Fig. 5C). Yoda1-induced IL-6
secretion was reduced by 50% in cardiac fibroblasts isolated
from hearts of Piezo1/mice compared with those fromWT
hearts (Fig. 5D), in keepingwith the reduction in Piezo1 expres-
sion and Ca2 response in these cells (Fig. 2, B and C). IL-6
secretion was unchanged following treatment of cardiac fibro-
blasts with compound 2e (Fig. 5D), an inactive analogue of
Yoda1 (16) that did not induce Ca2 entry in murine or human
cardiac fibroblasts or in HEK T-REx-293 cells heterologously
expressing mouse Piezo1 (Fig. S2, A–C). The Yoda1-induced
increase in IL-6 secretion depended on Piezo1, as evidenced by
attenuation of the secretion inmurine cardiac fibroblasts trans-
fected with Piezo1-specific siRNA (Fig. 5E). The same was true
in human cardiac fibroblasts, where the Yoda1-evoked increase
in Il6 mRNA expression was attenuated by Piezo1-specific
siRNA, and again the inactive Yoda1 analog 2e had no effect
(Fig. S2,D and E). These data establish that Yoda1 induces IL-6
expression in cardiac fibroblasts via a Piezo1-dependent
mechanism.
PamChipmultiplex serine/threonine kinase activity profiling
was used to assess differences in kinase activity following treat-
ment of murine cardiac fibroblasts with Yoda1 for 10 min.
Combinatorial analysis of phosphorylation of 140 peptide sub-
strates revealed a hierarchical list of predicted serine/threonine
kinases that were activated downstream of Piezo1 (Fig. 6A and
Table S1). Within the top 20 hits, two major kinase families
were identified: MAPKs (extracellular signal-regulated kinases
(ERK1/2/5), c-Jun N-terminal kinases (JNK1/2/3), and p38
mitogen-activated protein kinases (p38///)) and cyclin-
dependent kinases (CDK 1–7, 9, and 11) (Fig. 6A). The primary
role of CDK family kinases is to phosphorylate cell cycle pro-
teins and thereby regulate cell cycle progression, although it has
also been reported that specific CDKs can regulate inflamma-
Figure3.Cardiac fibroblasts expressmechanically activated ionic currents thatdependonPiezo1.Recordingsweremade fromcell-attachedpatcheson
human cardiac fibroblasts. A constant holding voltage of80mVwas applied to the patch pipette to ensure a negativemembrane potential across the patch
(inside relative to outside). A rapid pressure clamp system applied 200-ms negative pressure (suction) steps of increasing magnitude to the patch pipette. A,
example data from an untransfected cell. The color code of the pressure steps (bottom panel) matches the color code of the current traces in the top panel. B,
meanS.E. data for experiments of the type shown inA, inwhich the total current during180msof eachpressurepulsewas summed forn7–8patches/data
point. The fitted curve is the Boltzmann function,whichgave amidpoint for 50%activationof61.3mmHg.C, as forAbut froma cell thatwas transfectedwith
Piezo1 siRNA. D and E, each color shows the individual data for all recordings from cells transfected with control siRNA (D, n 24 recordings) or Piezo1 siRNA
(E, n 21 recordings). As for B, the total current during 180ms of each pressure pulsewas summed. Two-way ANOVA: p 0.0475, F 3.95 (siRNA); p 0.0001,
F  4.15 (pressure); p  0.0001, F  4.16 (interaction). In D and E, data values exceeding approximately 600 pA are clipped to maximize visibility of the
majority of the data, but all data values were included in the statistical analysis. The two large current values in the Piezo1 siRNA group may have been from
nontransfected cells because the transfection efficiency was estimated to be 90%.
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tory gene expression through interaction with the NF-B path-
way (18). However, given that kinases within the NF-B path-
way (IKK, IKK) were not activated in response to Yoda1 in
our experiments (Table S1), we did not pursue the role of CDKs
further. Subsequent experiments were therefore under-
taken with selective pharmacological inhibitors of the ERK
(PD98059), JNK (SP600125), and p38MAPK (SB203580) path-
ways to identify which were required for expression of Il6
mRNA in response to Piezo1 activation inmurine cardiac fibro-
blasts (Fig. 6, B–D). Of these, only SB203580 significantly
reduced theYoda1-induced increase in Il6mRNA levels back to
basal levels (Fig. 6D), suggesting an important role for the p38
MAPK pathway in Yoda1-induced Il6 gene expression. In
agreement, SB203580 also inhibited Yoda1-induced IL-6 pro-
tein secretion by 80% (Fig. 6E).
Western blotting was used to investigate whether the p38
MAPK pathway was stimulated following Piezo1 activation.
Yoda1 increased p38 phosphorylation (activation) after 10 min
before returning to basal levels after 30 min (Fig. 7A). Further
studies investigating p38 activation revealed that Yoda1-in-
Figure 4. Effect of Yoda1 on gene expression and cell survival in cardiac fibroblasts. A–G, RT-PCR analysis of murine cardiac fibroblasts treated with
concentrations of Yoda1 ranging from 0.5–10M or DMSO vehicle for 24 h (n 3). All mRNA expression levels were normalized to those of the housekeeping
gene Gapdh. Repeated measures one-way ANOVA: p 0.0010, F 8.9. Post hoc test: *, p 0.05; **, p 0.01; ***, p 0.001 versus vehicle-treated cells. H,
live/dead cell assay performed on culturedmurine cardiac fibroblasts treated with either vehicle (Veh), 10M Yoda1, or 1M staurosporine (SSP) for 24 h. The
bar chart showsmeandata for viable cells as a percentage of total cells. Repeatedmeasures one-wayANOVA: p 0.0028, F 10.6 (n 3). Post hoc test: **, p
0.01; NS, not significant versus vehicle-treated cells. I, representative images from the live/dead cell assay. Green indicates live cells; red indicates dead cells.
Bottom panels are magnified images of the indicated regions in the top panels.
Cardiac fibroblast Piezo1 activation induces IL-6 secretion
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duced p38 phosphorylation occurred in a concentration-de-
pendent manner and that p38 was not activated in response to
the inactive Yoda1 analog 2e (Fig. 7B). Piezo1-specific siRNA
reduced Yoda1-induced activation of p38 in bothmurine (Fig.
7C) and human (Fig. 7D) cardiac fibroblasts, confirming the
role of Piezo1 in Yoda1-induced p38 activation. The p38 inhib-
itor SB203580 significantly reduced the Yoda1-induced
increase in p38 phosphorylation (Fig. 7E). Furthermore, p38
activation following Yoda1 treatment was shown to be depen-
dent on the presence of extracellular Ca2 (Fig. 7F), indicating
that it is Ca2 entry through the Piezo1 channel that is impor-
tant for downstream signaling. Together, these data demon-
strate that Ca2-induced p38 MAPK activation is essential for
inducing the expression and secretion of IL-6 in response to
Piezo1 activation.
Discussion
The three main findings of this study are that human and
mouse cardiac fibroblasts express functional Piezo1 channels
coupled to a rapid rise in intracellular Ca2, that these channels
are mechanosensitive, and that Piezo1 activation is coupled to
secretion of IL-6 via a p38 MAPK-dependent pathway. These
Figure5.ActivationofPiezo1 is coupled to IL-6expression.A, RT-PCRanalysis of IL6mRNAexpression (left panel) andELISAanalysis of IL-6protein secretion
(right panel) after exposureof humancardiac fibroblasts to 24-h cyclical stretch (1Hz, 10%stretch) on collagen-coatedBioFlexplates comparedwith fibroblasts
maintained in parallel under static conditions. Cardiac fibroblasts were transfected previously with either control siRNA (C. si.) or Piezo1-specific siRNA (P1 si.).
RT-PCR data are expressed as percent of the housekeeping control GAPDH. Repeated measures two-way ANOVA for RT-PCR (n  3): p  0.0704, F  12.7
(siRNA);p0.403, F1.1 (stretch);p0.754, F0.13 (interaction). Post hoc test: *,p0.05. Repeatedmeasures two-wayANOVA for ELISA (n3):p0.0268,
F35.8 (siRNA);p0.1545, F5.0 (stretch);p0.838, F0.05 (interaction). Post hoc test: not statistically significant.B andC,murine cardiac fibroblastswere
exposed to vehicle (Veh) or 10MYoda1 for 2–24hbeforemeasuring Il6mRNA levels by RT-PCR,where expression ismeasured as percent of thehousekeeping
controlGapdh (B) or analyzing conditionedmedium for IL-6 levels by ELISA (C) (both n 3). Comparison of the area under the curve by paired t test: *, p 0.05
for the effect of Yoda1 on IL-6 expression at bothmRNA and protein levels.D, cardiac fibroblasts fromWT (n 4) and Piezo1/ (Het, n 3)mice were treated
with vehicle, 10M Yoda1, or compound 2e for 24 h before measuring IL-6 levels in conditionedmedium using ELISA. Two-way ANOVA: p 0.0001, F 24.9
(compound); p 0.1041, F 3.1 (genotype); p 0.615, F 0.51 (interaction). Post hoc test: ***, p 0.001; **, p 0.01 for the effect of Yoda1 versus vehicle.
All other changes were not statistically significant. E, mouse cardiac fibroblasts were transfected with control or Piezo1-specific siRNA and treated with either
vehicle or 10 M Yoda1 for 24 h before collecting conditioned media and measuring IL-6 levels by ELISA (n 3). Repeated measures two-way ANOVA: p
0.2349, F 2.82 (siRNA); p 0.2187, F 3.13 (Yoda1); p 0.064, F 14.2 (interaction). Post hoc test: NS, not significant versus vehicle-treated cells.
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data establish a link between cardiac fibroblast Piezo1 and
secretion of paracrine signaling molecules that can modulate
cardiac remodeling.
We established that murine and human cardiac fibroblasts
express Piezo1 mRNA at levels similar to those found in
endothelial cells from various sources, which are known
to express high levels of functional Piezo1 (14). Piezo1 mRNA
expression was 20 times higher in cardiac fibroblasts than in
cardiomyocytes. The EC50 values of Yoda1 acting on endog-
enous Piezo1 in murine and human cardiac fibroblasts (0.72
M and 0.71 M, respectively) were comparable with our
previous report of 0.23 M in HUVECs (16). When artifi-
cially overexpressed in cell lines, our data on mouse Piezo1
in HEK T-REx-293 cells (EC50 0.33M) were broadly com-
parable with human Piezo1 expressed in HEK T-REx-293
cells (EC50  2.51 M) (16) and somewhat lower than those
originally reported in HEK293T cells transiently transfected
with mouse (EC50  17.1 M) or human (EC50  26.6 M)
Piezo1 (11). It is worth noting that we could only use Yoda1
at concentrations up to 10 M because of solubility prob-
lems, so these EC50 values are estimates.
The ability of common inhibitors of mechanosensitive ion
channels, gadolinium and ruthenium red (10), and the novel
Yoda1 antagonist Dooku1 (16) to decrease the Yoda1-evoked
Ca2 entry inmurine and human cardiac fibroblasts correlated
with the expected properties of the channel. Themechanismby
which Yoda1 modulates Piezo1 activation and gating has been
described recently (12). However, it has also been suggested
that Yoda1may have somePiezo1-independent effects in endo-
thelial cells (19). We further verified the importance of Piezo1
by showing that the Ca2, p38 MAPK, and IL-6 responses in
cardiac fibroblasts were all proportionally reduced by
siRNA-mediated knockdown of Piezo1 or by use of cells from a
global Piezo1/ heterozygous knockout mouse model (14).
Thus, the Yoda1 responses we observed in cardiac fibroblasts
were unequivocally due to activation of Piezo1.
Figure 6. Piezo1 activation induces MAP kinase signaling, with p38 MAPK being coupled to IL-6 expression. A, mouse cardiac fibroblasts were stimu-
lated with 10 M Yoda1 for 10 min before analyzing Ser/Thr protein kinase activity with PamChip multiplex kinase activity profiling (n  6). Kinases were
identified based on peptide substrate phosphorylation and ranked by specificity and statistical significance (only the top 40 are shown). See Table S1 for the
full dataset. The top kinase families predicted to be activated by Yoda1 were the MAPKs ERK1/2/5, JNK1/2/3, and p38/// (blue) and CDKs 1–7, 9, and 11
(orange). B–D, RT-PCR analysis of Il6 mRNA expression after exposure of murine cardiac fibroblasts to 30 M PD98059 (B, an ERK pathway inhibitor), 10 M
SP600125 (C, a JNK inhibitor), or 10M SB203580 (D, a p38MAPK inhibitor) for 1 h, followed by treatment with vehicle (Veh) or 10M Yoda1 for a further 24 h.
Expression is measured as percent of the housekeeping control Gapdh (n 7 for SB203580, n 5 for PD98059, and SP600125). Repeatedmeasures two-way
ANOVA for B: p 0.7738, F 0.133 (PD98059); p 0.0529, F 7.41 (Yoda1); p 0.069, F 6.08 (interaction). For C: p 0.6133, F 0.299 (SP600125); p
0.0020, F51.9 (Yoda1);p0.475, F0.62 (interaction). ForD:p0.0004, F52.1 (SB203580);p0.2942, F1.32 (Yoda1);p0.0028, F23.8 (interaction).
Post hoc test: ***, p 0.001;NS, not significant for the effect of inhibitor. E, murine cardiac fibroblasts were treatedwith vehicle or 10M SB203580 for 1 h and
then treated with either vehicle or 10 M Yoda1 for 24 h before collecting conditioned media andmeasuring IL-6 levels by ELISA (n 6). Repeated measures
two-way ANOVA: p 0.0217, F 10.8 (SB203580); p 0.0283, F 9.3 (Yoda1); p 0.0002, F 98.1 (interaction). Post hoc test: ***, p 0.001 for the effect of
SB203580.
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Our patch clampdata showed that increased pressure caused
increased inward currents up to a limit, consistent with the
presence of Piezo1 channels (10, 20). The amplitude of the cur-
rent was highly variable between patches; we suspect that the
variable amount of suction required to form the initial Giga-
seal was a contributor to the variability in current amplitude
(with greater suction apparently leading to smaller mechani-
cally activated currents). Prior work has suggested that overex-
pressed human Piezo1 channels require 43 mm Hg for 50%
activation (20), but the difference between this value and what
we observed (61.3 mm Hg) may reflect the influence of the
native environment on channel properties at natural density.
Although the kinetics of the currents were relatively slow and
did not show inactivation, which contrasts with data for over-
expressed Piezo1 channels (10), prior work has suggested that
endogenous Piezo1 channels have slower kinetics and inacti-
vate slowly or not at all (14, 21). These data suggest that Piezo1
channel activity most likely explains these mechanically acti-
vated currents in human cardiac fibroblasts.
Prolonged exposure toYoda1 increased IL-6mRNAandpro-
tein expression in a Piezo1-dependent manner in both human
and mouse cardiac fibroblasts. IL-6 is a pleiotropic pro-inflam-
matory cytokine that promotes cardiac fibroblast proliferation
and fibrosis (22) as well as cardiac hypertrophy through its
actions on cardiomyocytes (23) and is readily secreted by car-
diac fibroblasts in culture (24).Mechanical stretching of cardiac
fibroblasts induces expression of several pro-fibrotic cytokines
(1, 25), although IL-6 expression does not appear to bemechan-
Figure 7. Yoda1-induced p38 MAPK phosphorylation depends on Piezo1. Cellular protein samples were immunoblotted for p-p38 and reprobed with
antibody for total p38 to confirm equal protein loading. The bar charts showmean densitometric data of p-p38 normalized to p38 expression. A, murine
cardiac fibroblasts (n 6) treated with DMSO vehicle (V) or 10M Yoda1 (Y) for 5–30min. *, p 0.05 versus vehicle-treated cells (repeatedmeasures one-way
ANOVA,p 0.0085). B,murine cardiac fibroblasts (n 3) treated for 10minwith varying concentrations of Yoda1 (2–10M) or 10Mcompound2e. *,p 0.05;
NS, not significant versus vehicle-treated cells (repeated measures one-way ANOVA, p 0.0122). C and D, murine (C) or human (D) cardiac fibroblasts (n 3)
transfected with either scrambled or Piezo1-specific siRNA before treatment with vehicle or 10M Yoda1 for 10min. Repeatedmeasures two-way ANOVA for
C: p 0.0202, F 48.0 (Yoda1); p 0.3045, F 1.87 (siRNA); p 0.0903, F 9.6 (interaction). Repeatedmeasures two-way ANOVA forD: p 0.0282, F 34.0
(Yoda1); p 0.2669, F 2.32 (siRNA); p 0.478, F 0.75 (interaction). Post hoc test: not significant. E, murine cardiac fibroblasts (n 3) exposed to 10 M
SB203580 for 1 h before treatmentwith vehicle or 10M Yoda1 for 10min. Repeatedmeasures two-way ANOVA: p 0.0312, F 30.6 (Yoda1); p 0.5898, F
0.40 (SB203580); p 0.0148, F 65.9 (interaction). Post hoc test: **, p 0.01; *, p 0.05. F, murine cardiac fibroblasts (n 3) treated for 10 min with vehicle
or 10M Yoda1 in either standard DMEM or DMEM containing 1.75 mM EGTA to chelate free Ca2. Repeatedmeasures two-way ANOVA: p 0.0123, F 79.5
(Yoda1); p 0.5739, F 0.44 (Ca2); p 0.128, F 6.34 (interaction). Post hoc test: not significant.
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ically regulated in human cardiac fibroblasts (26), as we found
in this study. This is in contrast to fibroblasts from various
other noncardiac sources that have been shown to secrete IL-6
in response to mechanical stretch (27–29).
Although cyclic stretch did not modulate IL-6 expression in
human cardiac fibroblasts (and no role for Piezo1 was found), it
was apparent from the stretch experiments that Piezo1 siRNA
could reduce basal IL-6 expression. This was evident only when
cells were grown on the softer collagen-coated substrate of the
BioFlex plates but not on the rigid plastic of regular tissue cul-
ture plates. Thus, Piezo1 may play a role in detecting altered
substrate stiffness and/or composition and modulate IL-6
expression accordingly. It has been shown previously that
stretch-induced expression of several cardiac fibroblast genes
depends on matrix stiffness (3, 25); hence, there is a complex
interplay of mechanosignaling pathways that convert these dif-
ferentmechanical stimuli into alterations in cellular phenotype.
Further studies are required to more precisely determine the
role of substrate stiffness in regulating IL-6 secretion in cardiac
fibroblasts.
The p38 family of stress-activated MAPKs is known to play
an important role in cardiac signaling and is activated in both
acute and chronic cardiac pathologies (30). Recently, a key role
for p38 in regulating multiple aspects of cardiac fibroblast
function has emerged (31). For example, fibroblast-specific
knockout ofMapk14, the gene encoding p38, revealed a crit-
ical role for this kinase in driving cardiac myofibroblast differ-
entiation and fibrosis in response to ischemic injury or chronic
neurohumoral stimulation (32). In a similar model, we estab-
lished a role for cardiac fibroblast p38 in stimulating cardiac
hypertrophy after chronic-adrenergic stimulation anduncov-
ered a potential role for IL-6 acting as a paracrine inducer of
cardiomyocyte hypertrophy in this context (15). We have also
shown an important role for p38 in cytokine-induced IL-6
expression and secretion in cultured human cardiac fibroblasts
(33). Thus, Piezo1-mediated activation of p38 in cardiac fibro-
blasts and subsequent secretion of IL-6may be important in the
cardiac remodeling process. Interestingly, hydrostatic pressure
can stimulate p38MAPK signaling throughPiezo1 activation in
mesenchymal stem cells (34).
In conclusion, our study establishes that Piezo1 is a func-
tional mechanosensitive Ca2-permeable ion channel in car-
diac fibroblasts and is coupled to altered expression of genes
important to the remodeling process. Specifically, activation of
Piezo1 induces expression and secretion of IL-6, a pro-hyper-
trophic cytokine with important roles after cardiac injury. Fur-
thermore, we revealed that p38MAPK is activated downstream
of Piezo1-mediated Ca2 entry to cause increased IL-6 secre-
tion. Functional studies and in vivo investigation into the role
of Piezo1 in cardiac fibroblasts are warranted to provide addi-
tional information regarding its role in regulating cardiac
remodeling.
Experimental procedures
Reagents
Yoda1 (Tocris), staurosporine (Sigma), PD98059 (Merck),
SP600125 (Cambridge Bioscience), and SB203580 (Merck)
were all solubilized in DMSO. ATP, gadolinium, and ruthe-
nium red were all obtained from Sigma-Aldrich and dissolved
in H2O. Dooku1 and compound 2e (16) were synthesized at the
University of Leeds and solubilized in DMSO.
Mouse cardiac fibroblast culture
Adult C57BL/6J mice were euthanized according to guide-
lines of The UK Animals (Scientific Procedures) Act (1986).
Cardiac fibroblast cultures were established from collagenase-
digested hearts and cultured inDMEMsupplementedwith 10%
fetal calf serum as described previously (15). All cells were kept
at 37 °C and 5%CO2 throughout the study. Cells were studied at
passage 1–2. Cells were kept in serum-free DMEM for 16 h
prior to treatment to collect RNA, lysates, and conditioned
media.
Human cell culture
Biopsies of human atrial appendages and long saphenous
veins were obtained from patients undergoing elective coro-
nary artery bypass grafting at the Leeds General Infirmary fol-
lowing local ethical committee approval and informed patient
consent. The study complied with the principles of the Decla-
ration of Helsinki. Cells were harvested and cultured as
described previously for cardiac fibroblasts (35) and saphenous
vein endothelial cells (36). Experiments were performed on
human cardiac fibroblasts from passages 2–5. Serum-free
DMEMwas used for 1 h prior to treatment to collect RNA and
conditioned media. HUVECs were purchased from Lonza and
cultured in endothelial cell growth medium (EGM-2, Lonza),
supplemented with 2% fetal calf serum and the EGM-2 Single-
Quots Kit (Lonza). HUVECs were used at passage 2.
Mouse pulmonary endothelial cell culture
CD146 pulmonary endothelial cells were isolated with
immunomagnetic microbeads (Miltenyi) and cultured in MV2
medium (Promocell) supplemented with 10% fetal calf serum,
100 units/ml penicillin, and 100 mg/ml streptomycin. Cells
were studied at passage 1.
HEK T-Rex-293 cell culture
pcDNA3_mouse Piezo1_IRES_GFP, a kind gift from Ardem
Patapoutian (10), was used as a template to clone the mouse
Piezo1 coding sequence into pcDNA4/TO. Overlapping
mouse Piezo1 (forward primer 5	-GTAACAACTCCGCCC-
CATTG-3	 and reverse primer 5	-GCTTCTACTCCCTCTC-
ACGTGTC-3	) and pcDNA4/TO (forward primer 5	-GACA-
CGTGAGAGGGAGTAGAAGCCGCTGATCAGCCTCGA-
CTG-3	 and reverse primer 5	-CAATGGGGCGGAGTTGT-
TAC-3	) PCR products were assembled using Gibson Assembly
(New England Biolabs) (37). This construct does not contain
tetracycline operator sequences.HEKT-REx-293 cells (Invitro-
gen) were transfected with pcDNA4/TO-mPiezo1 using Lipo-
fectamine 2000 (Invitrogen) and treated with 200g/ml zeocin
(InvivoGen) to select stably transfected cells. Individual clones
were isolated and analyzed for expression using Yoda1 and
intracellular Ca2 measurements. HEK T-REx-293 cells were
maintained in DMEM supplemented with 10% fetal calf serum
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and 1% penicillin/streptomycin (Sigma-Aldrich). Nontrans-
fected HEK T-Rex-293 cells were used as control cells.
Cardiac cell fractionation
Nonmyocyte cardiac cell fractions were prepared as
described previously (15). Briefly, collagenase-digested heart
tissue was filtered through a 30-m MACS Smart Strainer
(Miltenyi) to remove cardiomyocytes. Nonmyocytes were then
separated into two fractions using a cardiac fibroblastmagnetic
antibody cell separation kit (Miltenyi). “Nonfibroblasts”
(Pecam1-positive endothelial cells and leukocytes) were col-
lected in fraction 1, and “fibroblasts” (Col1a1/Col1a2/Ddr2/
Pdgfra-positive) were collected in fraction 2, as characterized
previously (15). Separately, adult mouse cardiomyocytes were
isolated from ventricles of 8-week-old WT mice. Hearts were
cannulated through the aorta and perfused for 5 min with per-
fusion buffer (124.5 mMNaCl, 10 mMHEPES, 11.1 mM glucose,
1.2 mM NaH2PO4, 1.2 mM MgSO4, 4 mM KCl, and 25 mM tau-
rine (pH 7.34)) containing 10 mM butanedione monoxime, fol-
lowed by perfusion buffer containing 1 mg/ml type 2 collagen-
ase, 0.05 mg/ml protease and 12.5 MCaCl2 for 7–15 min until
suitable digestion was observed. Ventricles were gently cut in
perfusion solution containing 10% FBS and 12.5 M CaCl2 and
filtered. This stepwas repeated in perfusion solution containing
5% FBS and 12.5 M CaCl2 and, finally, perfusion solution con-
taining only 12.5 M CaCl2. The filtrate was pelleted by gravity
for 5min before resuspension in perfusion buffer containing 0.5
mM CaCl2. This step was repeated with increasing concentra-
tions of CaCl2 (1.5 mM, 3.5 mM, 8 mM, and 18 mM). Finally, the
cell pellet was resuspended in 1 ml TRIzol. RNA was extracted
from cardiac cell fractions, and quantitative RT-PCR was used
to quantify gene expression.
Quantitative RT-PCR
For gene expression studies, cardiac fibroblasts were treated
with Yoda1 or vehicle (DMSO) for the indicated time. RNAwas
extracted from cultured/fractionated cells with the Aurum
RNA Extraction Kit (Bio-Rad). cDNA was synthesized using a
reverse transcription system (Promega). Real-time RT-PCR
was performed with the ABI-7500 system, gene expression
master mix, and specific TaqMan primer/probe sets (Thermo
Fisher Scientific): mouse Col1a1 (Mm01302043_g1), mouse
Col3a1 (Mm01254476_m1), mouse Piezo1 (Mm01241545_g1),
humanPIEZO1 (Hs00207230_m1),mouse Il1b (Mm00434228_m1),
mouse Il6 (Mm00446190_m1), human IL6 (Hs00174131_
m1), mouse Mmp3 (Mm00440295_m1), and mouse Mmp9
(Mm00442991_m1). Data are routinely expressed as the per-
centage of mouse Gapdh (Mm99999915_g1) or human
GAPDH (Hs99999905_m1) housekeeping gene mRNA
expression using the formula 2
CT  100, in which CT is
the cycle threshold number. For analysis of cardiac cell frac-
tions, three housekeeping genes were used to mitigate the
effects of any variation in expression of housekeeping genes
between cell fractions: Gapdh (Mm99999915_g1), Hprt
(Mm03024075_m1), and Actb (Mm00607939_s1). Data were
expressed relative to the geometric mean of the pooled house-
keeping gene expression using the formula 2
CT.
Piezo1-modifiedmice
Animal use was authorized by the University of Leeds Ani-
mal Ethics Committee and by the UK Home Office under pro-
ject license P144DD0D6. Animals were maintained in individ-
ually ventilatedOptimice cages (AnimalCare Systems) at 21 °C,
50–70% humidity, 12 h/12 h light/dark cycle, RM1 diet (Special
Diet Services) ad libitum, and Pure’o Cell bedding (Datesand).
C57BL/6 mice carrying global disruption of the Piezo1 gene
with a lacZ insertion flanked by Flp recombinase target sites
have been described previously (14). Identification of WT and
Piezo1/micewas performed by genotyping using primers for
LacZ: forward, AATGGTCTGCTGCTGCTGAAC; reverse,
GGCTTCATCCACCACATACAG. Mice of varying ages and
sexes were used for experiments.
Western blotting
Cells were treated with vehicle (DMSO), Yoda1, or com-
pound 2e at the appropriate times prior to lysing. Cells were
harvested in lysis buffer containing 10 mM Tris (pH 7.5), 150
mM NaCl, 0.5 mM EDTA, 0.5% NP-40, MiniComplete protease
inhibitors (Roche), and PhosSTOP phosphatase inhibitors
(Roche). A protein quantification assay was then performed
using the DC Protein Assay (Bio-Rad). 25 g of protein was
loaded on a 10% polyacrylamide gel. After resolution by elec-
trophoresis, samples were transferred to PVDF membranes,
and Western blotting was performed as described previously
(38) using a primary antibody for phospho-p38 MAPK (9215,
Cell Signaling Technology). Membranes were reprobed with
p38 antibody (9228, Cell Signaling Technology) to confirm
equal protein loading. Species-appropriate secondary antibod-
ies (GEHealthcare) and ECL PrimeWestern blotting detection
reagent (GE Healthcare) were used for visualization. Syngene
G:BOX Chemi XT4 was used for imaging alongside GeneSys
image acquisition software for densitometric analysis.
Intracellular Ca2measurements
Changes in [Ca2]i were measured using the ratiometric
Ca2 indicator dye Fura-2/AMand a 96-well fluorescence plate
reader (FlexStationII384, Molecular Devices) controlled by
SOFTmax PRO software v5.4.5. Cardiac fibroblasts and
HUVECswere plated in clear 96-well plates (Corning) andHEK
T-REx-293 cells in black, clear-bottomed 96-well plates (Gre-
nier) at a confluence of 90% 24 h before experimentation. Cells
were incubated for 1 h at 37 °C in standard bath solution (SBS;
130 mM NaCl, 5 mM KCl, 8 mM D-glucose, 10 mM HEPES, 1.2
mMMgCl2, and 1.5mMCaCl2 (pH 7.4)) containing 2M Fura-2
in the presence of 0.01% pluronic acid (Thermo Fisher Scien-
tific) to aid dispersion. During all Fura-2 assays involving car-
diac fibroblasts, 2.5 mM probenecid (Sigma-Aldrich) was pres-
ent to prevent extrusion of the Fura-2 indicator (39). Cells were
washed with SBS and then incubated at room temperature for
30 min, during which time inhibitors were added when appli-
cable. Stimuli were injected at 60 s of recording. The change in
intracellular Ca2 concentration (
[Ca2]i) was measured as
the ratio of Fura-2 emission (510 nm) intensity at 340 nm and
380 nm.
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Gene silencing
Murine cardiac fibroblasts were grown to 80% confluence
and transfected with 10 nM Piezo1-specific Silencer Select Pre-
Designed siRNA (4390771, siRNA s107968, Life Technologies)
or Silencer Select Negative Control No. 1 siRNA (4390843, Life
Technologies) using Lipofectamine RNAiMAX reagent (Life
Technologies) in Opti-MEM (Gibco) according to the manufa-
cturer’s instructions. Medium was replaced with full-growth
medium 24 h later. For human cardiac fibroblasts, cells were
grown to 90% confluence and transfected with 20 nM Piezo1-
specific Silencer Select Pre-designed siRNA (4392420, siRNA
s18891, Thermo Fisher Scientific) or ON-TARGETplus Non-
targeting Pool siRNA (D-01810-10-20, Dharmacon) using
Lipofectamine 2000 inOpti-MEMaccording to themanufactu-
rer’s instructions. Medium was replaced with full-growth
medium after 4.5 h. Cells were used for experimentation 48 h
after transfection.
Patch clamp electrophysiology
Ionic currents were recorded through cell-attached
patches using a standard patch clamp technique in voltage
clamp mode. Patch pipettes had a resistance of 4–6
megaohm when filled with pipette solution. An ionic solu-
tion composed of 145 mM CsCl, 2 mM MgCl2, 10 mM HEPES,
5 mM ATP, 0.1 mM GTP, and 1 mM EGTA (titrated to pH 7.2
using CsOH) was used in the pipette. The bath solution was
SBS. Recordings were at a constant holding potential of80
mV (applied to the patch pipette). 200-ms pressure steps
were applied to the patch pipette with an interval of 10 s
using a high-speed pressure clamp HSPC-1 system (ALA
Scientific Instruments). All recordings were made with
an Axopatch-200B amplifier (Axon Instruments, Inc.)
equipped with Digidata 1550B and pClamp 10.6 software
(Molecular Devices) at room temperature. Currents were
filtered at 2 kHz and digitally sampled at 20 kHz. Data were
analyzed using pClamp 10.6 and the MicroCal Origin 2018
(OriginLab Corp.) software packages. All recordings were
made blind (i.e. without knowledge of which cells had been
transfected with control or Piezo1 siRNA).
Cell viability assay
Cardiac fibroblasts were plated at 80% confluency and
incubated overnight (37 °C, 5% CO2). Vehicle (DMSO),
Yoda1 (10 M), or staurosporine (1 M) were applied the
following day, and cells were incubated for 24 h prior to
commencing the live/dead cell viability assay (Thermo
Fisher Scientific) according to the manufacturer’s instruc-
tions. Cells were imaged using the IncuCyte ZOOM Live
Imaging System (Essen Bioscience). The total number of flu-
orescent cells in each well was calculated using built-in algo-
rithms, using an average from 9 images/well of a 12-well
plate. The mean data are shown as the number of live cells
relative to the total number of cells.
Stretch experiments
Human cardiac fibroblasts were seeded at 1 105 cells/well
on collagen-coated membranes (BioFlex 6-well culture plates).
72 h after transfection, cells were stretched while in serum-free
medium using an FX-4000 or FX-5000 Flexercell Tension Sys-
tem (Flexcell International) to equibiaxially elongate the cell-
seeded elastic membrane against a loading post. Elongation at
10% strain and 1 Hz was applied to the cells for 24 h. A 6-well
stretching plate was housed in the incubator (37 °C, 5% CO2)
alongside unstimulated cells adhered to BioFlex plates, which
served as static controls. RNA was extracted, and conditioned
medium was collected. Quantitative RT-PCR and ELISA were
used to quantify gene and protein expression, respectively.
ELISA
Conditioned media were collected, centrifuged to remove
cellular debris, and stored at20 °C for subsequent analysis.
The concentration of IL-6 in the media was measured by
ELISA (M6000, R&D Systems) according to the manufactu-
rer’s instructions. Samples were diluted 1:5–1:30 prior to
analysis.
Multiplex kinase activity profiling
PamGene serine-threonine kinase (STK) multiplex activity
assays were used to investigate STK activity. Murine cardiac
fibroblasts were treated with vehicle or Yoda1 for 10 min, col-
lected, and lysed using mammalian protein extraction reagent
lysis buffer (Thermo Fisher Scientific) containing Halt phos-
phatase and Halt protease inhibitor cocktails (Pierce) for 30
min on ice. A protein quantification assay was then performed
as stated above, and samples were snap-frozen in liquid nitro-
gen. 1.2 g of protein was loaded onto each STK PamChip
array. Phosphorylation of PamChip peptides was monitored by
PamStation 12 following the manufacturer’s protocols as
described previously (40). Signal intensities were analyzed
using PamGene’s BioNavigator software as Yoda1-treated ver-
sus DMSO treatment after 10 min. Permutation analysis
resulted in a specificity score (mapping of peptides to kinases)
and a significance score (difference between treatment groups)
for each kinase. The combined score was used to rank and pre-
dict top kinase hits.
Statistical analysis
OriginPro 2015 (OriginLab) and GraphPad Prism version
7.05 (GraphPad Software) were used for data analysis, and
OriginPro 2015 was used to prepare the charts and graphs.
Averaged data are presented asmean S.E., wheren represents
the number of independent experiments and N indicates the
total number of replicates within the independent experiments.
Data were log-transformed prior to statistical analysis. For
comparisons between two sets of data, paired or unpaired
Student’s t tests were used as appropriate. For multiple com-
parisons with a single factor, one-way ANOVA was used (p
values in the figure legends) with Tukey post hoc test (p values
in the figures). For analysis of two factors, regular or repeated
measures two-way ANOVA was used (p values in the figure
legends) with Sidak post hoc test (p values in the figures). p 
0.05 was considered statistically significant. For IC50 determi-
nation, data were normalized to vehicle, and curves were fitted
using the Hill equation.
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